Chlamydia pneumoniae and future risk in patients with coronary heart disease

Author： Haim M. Tanne D. Battler A. Boyko V. Reshef T. Goldbourt U. Brunner D. Mekori Y.A. Behar S. for the Bezafibrate Infarction Prevention BIP Study Group

Publisher： Elsevier

ISSN： 0167-5273

Source： International Journal of Cardiology, Vol.93, Iss.1, 2004-01, pp. : 25-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Arterial stiffness and Chlamydia pneumoniae infection in coronary artery disease. Is there a link?

By Pitiriga Vassiliki Lekakis John Kotsis Vasilios Protogerou Athanasios Ikonomidis Ignatios Gennimata Vassilike Zakopoulos Nikos

Scandinavian Cardiovascular Journal, Vol. 40, Iss. 5, 2006-10 ,pp. : 285-290

Informa Healthcare

Access to resources Recommend Favorite

Prevalence of conventional risk factors in patients with coronary heart disease

By Khot U.N. Khot M.B. Bajzer C.T.

ACC Current Journal Review, Vol. 12, Iss. 6, 2003-11 ,pp. : 23-23

Elsevier

Access to resources Recommend Favorite

Chlamydia pneumoniae in Patients Undergoing Surgery for Thoracic Aortic Disease

By Nyström-Rosander Christina Hjelm Eva Lukinius Agneta Friman Göran Eriksson Lars Thelin Stefan

Scandinavian Cardiovascular Journal, Vol. 36, Iss. 6, 2002-11 ,pp. : 329-335

Informa Healthcare

Access to resources Recommend Favorite

Chlamydia pneumoniae in Elderly Patients with Stroke (C-PEPS): A Case-Control Study on the Seroprevalence of Chlamydia pneumoniae in Elderly Patients with Acute Cerebrovascular Disease

Cerebrovascular Diseases, Vol. 15, Iss. 1-2, 2003-01 ,pp. : 11-16

Karger

Access to resources Recommend Favorite

The Potential of SERMs for Reducing the Risk of Coronary Heart Disease

By Barrett-Connor E. Cox D.A. Anderson P.W.

Trends in Endocrinology and Metabolism, Vol. 10, Iss. 8, 1999-10 ,pp. : 320-325

Elsevier

Access to resources Recommend Favorite